readthroughSign in
CompanyIMVTNasdaqDurham, NC

Immunovant, Inc.

Immunovant is a clinical-stage immunology company developing anti-FcRn targeted therapies for autoimmune diseases.

424B3Nov 12Latest SEC filing
Nov 9Latest story

November 2026

August 2026